Hide Message

Updating the Resource Centre Digital Platform

The Business & Human Rights Resource Centre is at a critical point in its development. Our digital platform is home to a wealth of information on business and human rights, but hasn’t had a visual refresh for a number of years.

We will soon be updating the site to improve its usability and better serve the thousands of people that use our site to support their work.

Please take an advance peek at our new look, and let us know what you think!

Thank you,
Alex Guy, Digital Officer

Find Out More Hide Message

You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
en/glaxo-novo-merck-lead-on-access-to-medicines-according-to-new-ranking#c29536

2008 Index outcomes

Author: Access to Medicine Foundation, Published on: 18 June 2008

This web tool enables visitors to click and sort through the outcomes of the 2008 Access to Medicine Index. The tool presents ratings and rankings of the efforts of twenty of the world’s largest pharmaceutical companies to increase universal access to medicine. Companies can be ranked according to their overall performance or according to scores on one of eight ‘main criteria’...[includes link to full 2008 Access to Medicine Index report]

Read the full post here

Related companies: Abbott Laboratories AstraZeneca Bayer Bristol-Myers Squibb Cipla Eli Lilly Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Novartis Novo Group Novo Nordisk (part of Novo Group) Pfizer Ranbaxy Laboratories Roche Sanofi Schering-Plough Teva Pharmaceutical Wyeth (part of Pfizer)